Mefoxin
NDC Package 0006-3545-24

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Mefoxin is a . Marketed by Merck Sharp & Dohme Corp., this product is identified by NDC 0006-3545 and is authorized under FDA application ANDA063182.

Identification & Billing

NDC Package Code
0006-3545-24
Package Description
2 CARTON in 1 PACKAGE / 12 CONTAINER in 1 CARTON / 50 mL in 1 CONTAINER
Product Code
0006-3545
11-Digit Billing Format
00006354524

Clinical Specifications

Proprietary Name
Mefoxin
Dosage Form
-

Regulatory & Marketing

Labeler Name
Merck Sharp & Dohme Corp.
FDA Application #
ANDA063182
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-25-1993
End Marketing Date
01-28-2008
Listing Expiration
01-28-2008
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0006-3545-24 identifies a specific commercial package of 2 carton in 1 package / 12 container in 1 carton / 50 ml in 1 container of Mefoxin, labeled by Merck Sharp & Dohme Corp.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Merck Sharp & Dohme Corp. on January 25, 1993. The current certification is valid through January 28, 2008.

How is this Merck Sharp & Dohme Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00006354524. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0006-3545-24
11-Digit CMS (5-4-2)
00006-3545-24

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.